Loading…
Covista Inc. is projected to rise to $162.70 by 2027, a +24% move from its current price of $130.90. CVSA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $128.30 | $130.95 | $133.66 | +0.04% |
| Jul 14 | $127.26 | $131.00 | $134.85 | +0.08% |
| Jul 15 | $126.49 | $131.05 | $135.78 | +0.12% |
| Jul 16 | $125.84 | $131.10 | $136.58 | +0.16% |
| Jul 17 | $125.29 | $131.16 | $137.30 | +0.20% |
| Jul 18 | $124.79 | $131.21 | $137.95 | +0.23% |
| Jul 19 | $124.34 | $131.26 | $138.56 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $124.34 | $131.26 | $138.56 | +0.27% |
| Week 2 | $121.91 | $131.62 | $142.10 | +0.55% |
| Week 3 | $120.16 | $131.98 | $144.96 | +0.82% |
| Week 4 | $118.75 | $132.34 | $147.48 | +1.10% |
| Week 5 | $117.56 | $132.70 | $149.79 | +1.37% |
| Week 6 | $116.53 | $133.06 | $151.94 | +1.65% |
| Week 7 | $115.61 | $133.43 | $153.99 | +1.93% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Covista Inc. provides healthcare education across the United States, Barbados, St. Kitts, and St. Maarten. It operates in three segments: Chamberlain, Walden, and Medical and Veterinary, offering degree and non-degree programs including bachelor’s, master’s, and doctoral degrees, as well as online certificate programs for nursing, health professions, medical and veterinary postsecondary education, counseling, business, information technology, psychology, public health, social work and human services, public administration and public policy, and criminal justice.
It also operates Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
The company was formerly known as Adtalem Global Education Inc. and changed its name to Covista Inc. in February 2026. Covista Inc. was incorporated in 1987 and is headquartered in Chicago, Illinois.
Covista Inc. (CVSA) is currently priced at $127.53 with a market capitalization of $4.34B and a rank of 1483. The stock trades within a market position that places it among mid-cap educational services peers.
Looking ahead, the price forecast shows upside across the horizon, with the 2026 average at $127.53 and strong progression to higher levels through 2030 and beyond. The forecast projects a 2030 average of $300.02 and a 2050 average of $2,174.67, with substantial long-term upside implied by the max values in later years. Overall, sentiment in the forecast is bullish from 2027 onward, after a neutral start in 2026.
A major floor 23.1% below — a decisive break under it would weaken the trend.
The nearest floor, 10.4% below — buyers have tended to step in here.
The nearest ceiling, 3.6% above — a clean break opens room to run.
A major ceiling 11.6% above — clearing it would confirm fresh momentum.
Key CVSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $131.64 | Sell | $130.84 | Buy |
| MA 10 | $129.23 | Buy | $129.28 | Buy |
| MA 20 | $125.58 | Buy | $127.17 | Buy |
| MA 50 | $124.11 | Buy | $123.49 | Buy |
| MA 100 | $116.16 | Buy | $119.51 | Buy |
| MA 200 | $115.64 | Buy | $116.22 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.98 | Neutral |
| Stoch RSI (14) | 59.35 | Neutral |
| CCI (20) | 73.41 | Neutral |
| Williams %R (14) | -28.58 | Info |
| MACD (12,26,9) | 0.73 | Buy |
| ROC (12) | 8.42 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 71.42 | Neutral |
| TRIX (15) | 0.17 | Buy |
| Awesome (5,34) | 6.70 | Buy |
| Ultimate (7,14,28) | 67.54 | Neutral |
| Momentum (10) | 6.74 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 132.90 | Sell |
| ADX (14) | 15.16 | Neutral |
| ATR (14) | 2.26 | Info |
Sentiment is bullish in the near term, with a 14-day RSI of 50 and key averages near term. The SMA50 is $121.15 and the SMA200 is $116.05, suggesting constructive momentum as price fluctuates. Support is listed at $117.34 and resistance at $131.89, framing a 30-day range of $111.05 to $146.45.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $92.92 | $130.90 | $172.32 | 0% | Neutral | |
| $132.54 | $162.70 | $209.33 | +24% | Bullish | |
| $161.99 | $202.95 | $268.73 | +55% | Bullish | |
| $201.82 | $257.12 | $348.26 | +96% | Bullish | |
| $236.49 | $305.76 | $422.15 | +134% | Bullish | |
| $281.86 | $369.31 | $518.54 | +182% | Bullish | |
| $306.93 | $407.15 | $580.40 | +211% | Bullish | |
| $323.97 | $434.74 | $628.31 | +232% | Bullish | |
| $368.28 | $499.62 | $731.31 | +282% | Bullish | |
| $408.90 | $560.51 | $830.20 | +328% | Bullish | |
| $676.49 | $971.52 | $1,512.64 | +642% | Bullish | |
| $1,480.50 | $2,298.33 | $3,852.43 | +16.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $92.92 | $130.90 | $159.26 | +0.00% |
| August 2026 | $115.69 | $135.63 | $162.60 | +3.61% |
| September 2026 | $115.10 | $135.64 | $164.00 | +0.01% |
| October 2026 | $117.81 | $139.46 | $169.83 | +2.82% |
| November 2026 | $119.20 | $141.64 | $173.51 | +1.56% |
| December 2026 | $117.32 | $139.90 | $172.32 | -1.23% |
Click any year to see its month-by-month CVSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CVSA to range from $92.92 to $172.32 through 2026. The $130.90 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CVSA price prediction for 2027 points to an average of $162.70 (low $132.54, high $209.33) — a potential gain of +24% on today's $130.90. Buyers look set to stay in control over this stretch.
In 2028, CVSA is projected to trade between $161.99 and $268.73, averaging $202.95 — a potential gain of +55% from today's $130.90. That is up +25% on the projected 2027 average. Momentum favours further upside here.
Covista Inc.'s 2029 outlook centres on $257.12, within a $201.82 to $348.26 range. That is up +27% on the projected 2028 average. That marks a +96% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CVSA could reach as high as $422.15, with a base case around $305.76 and support toward $236.49 — roughly +134% from $130.90. Momentum favours further upside here.
Expect CVSA to range from $281.86 to $518.54 through 2031. The $369.31 average target implies a +182% move from current prices. That is up +21% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CVSA price prediction for 2032 points to an average of $407.15 (low $306.93, high $580.40) — a potential gain of +211% on today's $130.90. Momentum favours further upside here.
In 2033, CVSA is projected to trade between $323.97 and $628.31, averaging $434.74 — a potential gain of +232% from today's $130.90. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Covista Inc.'s 2034 outlook centres on $499.62, within a $368.28 to $731.31 range. That is up +15% on the projected 2033 average. That marks a +282% change versus current levels. Momentum favours further upside here.
By 2035, CVSA could reach as high as $830.20, with a base case around $560.51 and support toward $408.90 — roughly +328% from $130.90. Buyers look set to stay in control over this stretch.
Expect CVSA to range from $676.49 to $1,512.64 through 2040. The $971.52 average target implies a +642% move from current prices. That is up +73% on the projected 2035 average. Momentum favours further upside here.
The CVSA price prediction for 2050 points to an average of $2,298.33 (low $1,480.50, high $3,852.43) — a potential gain of +16.6x on today's $130.90. Buyers look set to stay in control over this stretch.
Investing $1,000 in CVSA today (≈ 7.639419 CVSA) could be worth
$17,557.87
+$16,557.87 (+1656%) by 2050 · US Dollar
Based on the average projected CVSA price of $2,298.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVSAwould be worth at today's price.
$1,000 invested in CVSA on Jul 10, 2025 (≈ 8.413967 CVSA) would be worth
$1,101.39
+$101.39 (+10.1%) today · 1.10× · US Dollar
Based on a CVSA entry price of $118.85 vs. today's $130.9.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $129.88 | $1,007.85 | +0.8% |
| 1 month ago | $130.25 | $1,004.99 | +0.5% |
| 3 months ago | $112.04 | $1,168.33 | +16.8% |
| 6 months ago | $116.05 | $1,127.96 | +12.8% |
| 1 year ago | $118.85 | $1,101.39 | +10.1% |
| All time (5.0y) ago | $37.56 | $3,485.09 | +248.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVSA forecast.
Our base-case forecast reaches $260.00 around 2030.
Implied market cap at $260.00: $8.85B
The year-by-year forecast shows a path of rising valuations and expanding upside. In 2026 the min is $92.92, the avg is $127.53, the max is $168.29, withROI of 0 and neutral sentiment. From 2027 onward, the outlook strengthens: 2027 avg $162.02, 2028 $195.99, 2029 $248.65, and 2030 $300.02 with a 135.3% ROI and bullish sentiment.
The momentum continues through 2031 ($354.76 avg, 178.2% ROI), 2032 ($391.89 avg, 207.3%), 2033 ($420.89 avg, 230%), 2034 ($475.67 avg, 273%), and 2035 ($541.05 avg, 324.3%). Long-horizon gains are substantial, with 2040 at $920.90 avg (622.1% ROI) and 2050 at $2,174.67 avg (1605.2% ROI), both labeled bullish. These figures illustrate an asset with strong growth expectations across the 2026–2050 window, acknowledging that forecasts are estimates and not guarantees and that investment outcomes carry uncertainty and risk.
Tap a question to reveal the answer.
Average price $300.02, min $231.19, max $416.19, ROI 135.3%, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages: 2027 avg $162.02, 2028 $195.99, 2029 $248.65, 2030 $300.02, 2040 $920.90, and 2050 $2,174.67, with escalating ROIs (e.g., 27% in 2027, 135.3% in 2030, 622.1% in 2040, 1605.2% in 2050).
Yes. The forecast lists 2031 max $500.61, 2032 max $561.57, and 2033 max $611.62.
Current price is $127.53.
30-day range low $111.05 and high $146.45; annualized volatility 40%.
Covista Inc. Community Discussion
0Share your Covista Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.